Cargando…
Feasibility of three times weekly symptom screening in pediatric cancer patients
OBJECTIVE: Primary objective was to determine the feasibility of three times weekly symptom reporting by pediatric cancer patients for eight weeks. METHODS: We included English-speaking patients 8–18 years of age with cancer. Patients were sent reminders by text or email to complete Symptom Screenin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809057/ https://www.ncbi.nlm.nih.gov/pubmed/36597030 http://dx.doi.org/10.1186/s12885-022-10400-1 |
_version_ | 1784863053602357248 |
---|---|
author | Calligan, Maryann Chakkalackal, Lauren Dadzie, Grace Tardif-Theriault, Cassandra Cook, Sadie Vettese, Emily Soman, Dilip Kuczynski, Susan Schechter, Tal Dupuis, L. Lee Sung, Lillian |
author_facet | Calligan, Maryann Chakkalackal, Lauren Dadzie, Grace Tardif-Theriault, Cassandra Cook, Sadie Vettese, Emily Soman, Dilip Kuczynski, Susan Schechter, Tal Dupuis, L. Lee Sung, Lillian |
author_sort | Calligan, Maryann |
collection | PubMed |
description | OBJECTIVE: Primary objective was to determine the feasibility of three times weekly symptom reporting by pediatric cancer patients for eight weeks. METHODS: We included English-speaking patients 8–18 years of age with cancer. Patients were sent reminders by text or email to complete Symptom Screening in Pediatrics Tool (SSPedi) three times weekly for eight weeks. When patients reported at least one severely bothersome symptom, the symptom report was emailed to the primary healthcare team. Patient-reported outcomes were obtained at baseline, week 4 ± 1 and week 8 ± 1. Symptom documentation, intervention provision for symptoms and unplanned healthcare encounters were determined by chart review at weeks 4 and 8. The primary endpoint was feasibility, defined as at least 75% patients achieving adherence with at least 60% of SSPedi evaluations. We planned to enroll successive cohorts until this threshold was met. RESULTS: Two cohorts consisting of 30 patients (cohort 1 (n = 20) and cohort 2 (n = 10)) were required to meet the feasibility threshold. In cohort 1, 11/20 (55%) met the SSPedi completion threshold. Interventions applied after cohort 1 included engaging parents to facilitate pediatric patient self-report, offering mechanisms to remember username and password and highlighting potential benefits of symptom feedback to clinicians. In cohort 2, 9/10 (90%) met the SSPedi completion threshold and thus feasibility was met. Patient-reported outcomes and chart review outcomes were obtained for all participants in cohort 2. CONCLUSIONS: Three times weekly symptom reporting by pediatric patients with cancer for eight weeks was feasible. Mechanisms to enhance three times weekly symptom reporting were identified and implemented. Future studies of longitudinal symptom screening can now be planned. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10400-1. |
format | Online Article Text |
id | pubmed-9809057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98090572023-01-04 Feasibility of three times weekly symptom screening in pediatric cancer patients Calligan, Maryann Chakkalackal, Lauren Dadzie, Grace Tardif-Theriault, Cassandra Cook, Sadie Vettese, Emily Soman, Dilip Kuczynski, Susan Schechter, Tal Dupuis, L. Lee Sung, Lillian BMC Cancer Research OBJECTIVE: Primary objective was to determine the feasibility of three times weekly symptom reporting by pediatric cancer patients for eight weeks. METHODS: We included English-speaking patients 8–18 years of age with cancer. Patients were sent reminders by text or email to complete Symptom Screening in Pediatrics Tool (SSPedi) three times weekly for eight weeks. When patients reported at least one severely bothersome symptom, the symptom report was emailed to the primary healthcare team. Patient-reported outcomes were obtained at baseline, week 4 ± 1 and week 8 ± 1. Symptom documentation, intervention provision for symptoms and unplanned healthcare encounters were determined by chart review at weeks 4 and 8. The primary endpoint was feasibility, defined as at least 75% patients achieving adherence with at least 60% of SSPedi evaluations. We planned to enroll successive cohorts until this threshold was met. RESULTS: Two cohorts consisting of 30 patients (cohort 1 (n = 20) and cohort 2 (n = 10)) were required to meet the feasibility threshold. In cohort 1, 11/20 (55%) met the SSPedi completion threshold. Interventions applied after cohort 1 included engaging parents to facilitate pediatric patient self-report, offering mechanisms to remember username and password and highlighting potential benefits of symptom feedback to clinicians. In cohort 2, 9/10 (90%) met the SSPedi completion threshold and thus feasibility was met. Patient-reported outcomes and chart review outcomes were obtained for all participants in cohort 2. CONCLUSIONS: Three times weekly symptom reporting by pediatric patients with cancer for eight weeks was feasible. Mechanisms to enhance three times weekly symptom reporting were identified and implemented. Future studies of longitudinal symptom screening can now be planned. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10400-1. BioMed Central 2023-01-03 /pmc/articles/PMC9809057/ /pubmed/36597030 http://dx.doi.org/10.1186/s12885-022-10400-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Calligan, Maryann Chakkalackal, Lauren Dadzie, Grace Tardif-Theriault, Cassandra Cook, Sadie Vettese, Emily Soman, Dilip Kuczynski, Susan Schechter, Tal Dupuis, L. Lee Sung, Lillian Feasibility of three times weekly symptom screening in pediatric cancer patients |
title | Feasibility of three times weekly symptom screening in pediatric cancer patients |
title_full | Feasibility of three times weekly symptom screening in pediatric cancer patients |
title_fullStr | Feasibility of three times weekly symptom screening in pediatric cancer patients |
title_full_unstemmed | Feasibility of three times weekly symptom screening in pediatric cancer patients |
title_short | Feasibility of three times weekly symptom screening in pediatric cancer patients |
title_sort | feasibility of three times weekly symptom screening in pediatric cancer patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809057/ https://www.ncbi.nlm.nih.gov/pubmed/36597030 http://dx.doi.org/10.1186/s12885-022-10400-1 |
work_keys_str_mv | AT calliganmaryann feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients AT chakkalackallauren feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients AT dadziegrace feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients AT tardiftheriaultcassandra feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients AT cooksadie feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients AT vetteseemily feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients AT somandilip feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients AT kuczynskisusan feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients AT schechtertal feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients AT dupuisllee feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients AT sunglillian feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients |